Eyenovia - Stock Price History | EYEN

Historical daily share price chart and data for Eyenovia since 2021 adjusted for splits. The latest closing stock price for Eyenovia as of September 24, 2021 is 4.84.
  • The all-time high Eyenovia stock closing price was 9.95 on January 26, 2018.
  • The Eyenovia 52-week high stock price is 7.72, which is 59.5% above the current share price.
  • The Eyenovia 52-week low stock price is 3.01, which is 37.8% below the current share price.
  • The average Eyenovia stock price for the last 52 weeks is 4.95.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Eyenovia Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 3.5537 4.3200 6.0600 1.7700 6.0600 35.27%
2019 4.1797 3.0000 6.8700 2.5500 4.4800 57.19%
2018 6.4265 9.9200 9.9500 2.6000 2.8500 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.122B $0.002B
Eyenovia, Inc. is a clinical stage biopharmaceutical company which engages in developing therapeutics for the treatment of prominent eye diseases primarily in the United States. Its product portfolio includes MicroProst, MicroStat, MicroTears and MicroPine which are in clinical stage. Eyenovia, Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71